Behavioral pharmacological profile of CGS 9895: A novel anxiomodulator with selective benzodiazepine agonist and antagonist properties
- 1 January 1985
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 6 (4) , 313-325
- https://doi.org/10.1002/ddr.430060404
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The non-sedating anxiolytic CGS 9896 produces discriminative stimuli that may be related to an anxioselective effectLife Sciences, 1985
- Modification of pyrazoloquinolinone affinity by GABA predicts efficacy at the benzodiazepine receptorEuropean Journal of Pharmacology, 1984
- In vivo determination of efficacy of pyrazoloquinolinones at the benzodiazepine receptorEuropean Journal of Pharmacology, 1984
- CGS 9896: A nonbenzodiazepine, nonsedating potential anxiolyticDrug Development Research, 1984
- The neuropharmacology of various diazepam antagonistsNeuropharmacology, 1983
- Behavioral analogues of anxiety animal modelsNeuropharmacology, 1983
- Quinolines and anxiety: Anxiogenic effects of CGS 8216 and partial anxiolytic profile of PK 9084Pharmacology Biochemistry and Behavior, 1983
- A novel pyrazoloquinoline that interacts with brain benzodiazepine receptors: Characterization of some and properties of CGS 9896.Life Sciences, 1982
- CGS 8216: Receptor binding characteristics of a potent benzodiazepine antagonistLife Sciences, 1982
- Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding.Proceedings of the National Academy of Sciences, 1977